Can a smartphone app with rewards boost opioid treatment success after an emergency?

NCT ID NCT05180669

Terminated Disease control Sponsor: Q2i, LLC Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a mobile app that uses rewards to encourage people with opioid use disorder to start and stick with medication-assisted treatment after an emergency room visit. 41 adults from two hospitals were given access to the app for 12 weeks. The goal was to see if the app helped more people schedule and complete their first treatment appointment and stay abstinent from opioids.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: OARSCM mobile app (reward-based platform) and MyMAT educational app
What this could lead to: If successful, this app-based approach could help more people with opioid addiction start and stay on medication-assisted treatment, reducing relapse and overdose risk.
What could go wrong: This was a small, early-phase trial that was terminated early, so results are limited. The app may not work for everyone, and long-term benefits are unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER

Contacts and locations

Locations

UMass Chan Medical School

Worcester, Massachusetts, 01655, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.